Adma Biologics Inc

ADMANASDAQ · USD
8.95USD0.00 (+0.57%)
845

Adma Biologics Inc (ADMA) Option Chain

As of September 17, 2026, Adma Biologics Inc is trading at $8.95, a +0.57% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 31.8%. IV Rank is 1%.

Read more

Tracking the ADMA option chain helps you see every strike and expiry on Adma Biologics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Adma Biologics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ADMA options activity at a glance. Use our scanner to monitor the ADMA option chain in real time and filter for the ADMA options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ADMA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ADMA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ADMA stock options are being actively traded and where they are not.

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S.

pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Adma Biologics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ADMA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ADMA stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile1.98% Subdued
  • Market cap (M$)2,005
  • 52 weeks high-56.26%
  • 52 weeks low24.13%
  • Analyst recommendationStrong Buy
    1.33
  • Target price$18.67
    108.60% above the current stock price
  • Dividend
  • Payout ratio0.00%
  • Earnings date2026-11-04
  • P/E12.70
  • Future P/E9.49
  • EPS (ttm)0.70
  • EPS growth next 5 years22.25%

As of September 17, 2026

2026-09-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.0000-0.071.951.102.657.00-21.350.100.000.1000100.00
0.22960-0.020.950.501.358.00-10.110.050.000.0502299.78
62.31248500.400.000.409.00+1.120.100.650.050.321024937.69
99.9267330.050.000.0510.00+12.363.101.052.05010.08
100.0019300.100.000.1011.00+23.601.603.802.050.65010.00

As of September 17, 2026

Scan the full option chain in one place

Browse the full ADMA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial